← All candidates
Five insider buys in the last year — $573.7K in all.
88 filings on record.
BLCOBausch & Lomb Corp
NYSE · Healthcare · $6.16B
$17.25
-1.99% · Sep 15
Five insider buys in the last year — $573.7K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 5 buys● 3 sells◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 1 move explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$6.16B
Float
45.5M
13% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
15.6
Price / sales
1.2
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Collis Steven H
Bought $267.1K on Feb 23 — 15,000 sh @ $17.81, held direct, 74% of their stake.
0 of 1 position beat the S&P
CEO and Chairman of the Board
Saunders Brent L
Bought $248.1K on May 22 — 22,000 sh @ $11.28, held direct, 3.1% of their stake.
1 of 1 position beat the S&P
Director
Von Eschenbach Andrew C.
Bought $79.9K on Feb 27 — 4,364 sh @ $18.31, held direct, 6.6% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
83 more transactions on Pro →Context
Wall St
$18.04 avg target
+4.6% vs today · 13 analysts · consensus Hold
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26$0.08 act+$0.03
Q4 '25$0.32 act−$0.04
Q3 '25$0.18 act+$0.02
Q2 '25$0.07 act−$0.01
Coverage
Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The RestStockStory · 05-21How Investors May Respond To Bausch + Lomb (BLCO) Surgical Launch and EBITDA MomentumSimply Wall St. · 05-17Bausch + Lomb Corporation (BLCO): Carl C. Icahn Likes This StockInsider Monkey · 05-13What Bausch + Lomb (BLCO)'s Upgraded 2026 Outlook and Narrowing Losses Mean For ShareholdersSimply Wall St. · 05-02
The file stays open
88 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice